|  |
| |
| |
| |
 |  |  |  |
    |
| PR:000050262 | severe acute respiratory syndrome coronavirus 2 protein | | |  | | |
| |
| |
| |
| |
 |  |  |  |  |  |
    |
| PR:000050265 | ORF7a protein, signal peptide removed form (SARS-CoV-2) | | |  | | |
| |
| |
 |  |  |  |  |  |
    |
| PR:000050264 | ORF8 protein, signal peptide removed form (SARS-CoV-2) | | |  | | |
| |
 |  |  |  |  |
    |
| PR:P0DTC4 | envelope small membrane protein (SARS-CoV-2) | | |  | | |
| |
| |
| |
 |  |  |  |  |
    |
| PR:P0DTF1 | putative ORF3b protein (SARS-CoV-2) | | |  | | |
 |  |  |  |  |
    |
| PR:P0DTG0 | putative ORF3d protein (SARS-CoV-2) | | |  | | |
 |  |  |  |  |
    |
| PR:P0DTD3 | putative ORF9c protein (SARS-CoV-2) | | |  | | |
| |
 |  |  |  |  |  |
    |
| PR:000050281 | rep gene proteolytic cleavage product (SARS-CoV-2) | | |  | | |
| |
| |
 |  |  |  |  |  |  |
    |
| PR:000050282 | ORF1a proteolytic cleavage product (SARS-CoV-2) | | |  | | |
| |
 |  |  |  |  |  |  |
    |
| PR:000050283 | ORF1ab proteolytic cleavage product (SARS-CoV-2) | | |  | | |
| |
| |
| |
 |  |  |  |  |  |  |  |
    |
| PR:000050286 | proofreading exoribonuclease nsp14 (SARS-CoV-2) | | |  | | |
 |  |  |  |  |  |  |  |
    |
| PR:000050287 | uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | | |  | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
 |  |  |  |  |  |  |
    |
| PR:000050282 | ORF1a proteolytic cleavage product (SARS-CoV-2) | | |  | | |
| |
| |
 |  |  |  |  |  |  |
    |
| PR:000050283 | ORF1ab proteolytic cleavage product (SARS-CoV-2) | | |  | | |
| |
| |
| |
 |  |  |  |  |  |  |  |
    |
| PR:000050286 | proofreading exoribonuclease nsp14 (SARS-CoV-2) | | |  | | |
 |  |  |  |  |  |  |  |
    |
| PR:000050287 | uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | | |  | | |
| |
 |  |  |  |  |  |
    |
| PR:000050266 | spike glycoprotein, signal peptide removed form (SARS-CoV-2) | | |  | | |
| |
| |
| |